ALMIRALL ALMIRALL S.A./ ES0157097017 /
6/7/2024 10:02:27 AM | Chg. +0.1000 | Volume | Bid10:02:32 AM | Ask10:02:54 AM | High | Low |
---|---|---|---|---|---|---|
9.4200EUR | +1.07% | 10,717 Turnover: 100,143.9650 |
9.4050Bid Size: 1,285 | 9.4250Ask Size: 370 | 9.4200 | 9.3150 |
GlobeNewswire
11/14/2023
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for de...
GlobeNewswire
9/27/2021
Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Ker...
GlobeNewswire
7/19/2021
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment ...